Medicaid Drug Utilization Review Program
The Medicaid Drug Utilization Review (DUR) Program was created by the Omnibus Budget Reconciliation Act of 1990. The main emphasis of the program is to promote patient safety by an increased review and awareness of outpatient prescribed drugs. States were encouraged by enhanced federal funding to design and install point-of-sale electronic claims management systems that interface with their MMIS operations. The annual report requirement provides an excellent measurement tool to assess how well states have implemented the DUR program and the effect DUR has had on patient safety, provider prescribing habits and dollars saved by avoidance of problems such as drug-drug interactions, drug-disease interactions, therapeutic duplication and over-prescribing by providers.
Coming Soon:
The new DUR annual report form and instructions for completing the form will be posted to this site by Fall 2002.
For more information please contact:
Altamease Arnold, (410) 786-5907 or E-mail aarnold@cms.hhs.gov.
Christina Lyon, (410) 786-3332 or E-mail clyon@cms.hhs.gov.
